Literature DB >> 11814838

Synthesis and enzymatic evaluation of pyridinium-substituted uracil derivatives as novel inhibitors of thymidine phosphorylase.

Paul E Murray1, Virginia A McNally, Stacey D Lockyer, Kaye J Williams, Ian J Stratford, Mohammed Jaffar, Sally Freeman.   

Abstract

A series of water soluble N(1)- and C(6)-substituted uracil pyridinium compounds were prepared as potential inhibitors of thymidine phosphorylase (TP). The C(6)-uracil substituted derivatives were the most active. 1-[(5-Chloro-2,4-dihydroxypyrimidin-6-yl)methyl]pyridinium chloride, was identified as the best inhibitor being 5-fold more potent than the known inhibitor, 6-amino-5-bromouracil.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11814838     DOI: 10.1016/s0968-0896(01)00309-1

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  3 in total

1.  Synthesis and preclinical evaluation of a new C-6 alkylated pyrimidine derivative as a PET imaging agent for HSV1-tk gene expression.

Authors:  Ursina Müller; Tobias L Ross; Charlene Ranadheera; Roger Slavik; Adrienne Müller; Mariana Born; Evelyn Trauffer; Selena Milicevic Sephton; Leonardo Scapozza; Stefanie D Krämer; Simon M Ametamey
Journal:  Am J Nucl Med Mol Imaging       Date:  2013-01-05

2.  Monitoring HSVtk suicide gene therapy: the role of [(18)F]FHPG membrane transport.

Authors:  A R Buursma; I J van Dillen; A van Waarde; W Vaalburg; G A P Hospers; N H Mulder; E F J de Vries
Journal:  Br J Cancer       Date:  2004-12-13       Impact factor: 7.640

3.  In vitro selection of DNA-cleaving deoxyribozyme with site-specific thymidine excision activity.

Authors:  Mingqi Wang; Huafan Zhang; Wei Zhang; Yongyun Zhao; Afshan Yasmeen; Li Zhou; Xiaoqi Yu; Zhuo Tang
Journal:  Nucleic Acids Res       Date:  2014-07-16       Impact factor: 16.971

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.